152 related articles for article (PubMed ID: 32755726)
1. miR-3666 inhibits development of hepatic steatosis by negatively regulating PPARγ.
Mittal S; Inamdar S; Acharya J; Pekhale K; Kalamkar S; Boppana R; Ghaskadbi S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158777. PubMed ID: 32755726
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
3. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
4. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
Kim JH; Jung DY; Nagappan A; Jung MH
Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
7. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
[TBL] [Abstract][Full Text] [Related]
8. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
9. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
10. MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling.
Ye D; Lou G; Zhang T; Dong F; Liu Y
J Cell Mol Med; 2018 Dec; 22(12):6167-6175. PubMed ID: 30338914
[TBL] [Abstract][Full Text] [Related]
11. Targeting of miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr-/- mice via p66shc/cytochrome C cascade.
Zhang Y; Wang C; Lu J; Jin Y; Xu C; Meng Q; Liu Q; Dong D; Ma X; Liu K; Sun H
Aging (Albany NY); 2020 Feb; 12(3):2049-2069. PubMed ID: 32023549
[TBL] [Abstract][Full Text] [Related]
12. MiR-451a attenuates free fatty acids-mediated hepatocyte steatosis by targeting the thyroid hormone responsive spot 14 gene.
Zeng N; Huang R; Li N; Jiang H; Li R; Wang F; Chen W; Xia M; Wang Q
Mol Cell Endocrinol; 2018 Oct; 474():260-271. PubMed ID: 29604329
[TBL] [Abstract][Full Text] [Related]
13. Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression.
Wu YL; Zhu YB; Huang RD; Peng XE; Lin X
Cell Physiol Biochem; 2017; 44(6):2243-2255. PubMed ID: 29258109
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
Lin HY; Wang FS; Yang YL; Huang YH
Cells; 2019 Oct; 8(10):. PubMed ID: 31652636
[TBL] [Abstract][Full Text] [Related]
15. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.
Guo J; Fang W; Sun L; Lu Y; Dou L; Huang X; Sun M; Pang C; Qu J; Liu G; Li J
Oncotarget; 2016 Jun; 7(24):36207-36219. PubMed ID: 27166182
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.
Lei L; Zhou C; Yang X; Li L
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):819-831. PubMed ID: 29569260
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1.
Gong R; Lv X; Liu F
Cell Mol Biol Lett; 2018; 23():16. PubMed ID: 29721023
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake.
Labrie M; Lalonde S; Najyb O; Thiery M; Daneault C; Des Rosiers C; Rassart E; Mounier C
PLoS One; 2015; 10(6):e0130230. PubMed ID: 26083030
[TBL] [Abstract][Full Text] [Related]
19. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]